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The theme for this year’s scientific session was “Controversies in
Medicine,” and a variety of topics were covered. On the first
morning Michael S. Mega MD, from University of California, Los
Angeles, spoke on the treatment of stroke and on the cause and
treatment of Alzheimer’s disease. He was followed by Eliseo J.
Perez-Stable MD, University of California, San Francisco, who
addressed cholesterol testing and cancer screening.
Dr Mega noted that the best treatment for stroke is prevention, and
when stroke does occur, it should be regarded as an acute emer
gency. For maximum benefit, therapy should be initiated within two
hours of the onset of symptoms. Treatment centers should establish
emergency stroke teams to handle these patients. The goals of initial
treatment are to optimize cerebral perfusion, oxygenation and
metabolism, to stabilize blood pressure and to normalize blood
glucose. Language abnormality indicates large vessel disease.
Thrombolysis and carotid endarterectomy were discussed. Blood
pressure control should not be too strict, especially in those with a
prior history of hypertension, to avoid loss of cerebral perfusion.
Hyperglycemia indicates a poor prognosis; blood sugar should be
maintained at 100-200 mg %. Patients need to be followed closely
for brain edema (peak incidence on days 3 to 5) and treated promptLy
with mannitol and hyperventilation. Steroids should not be used. Dr
Mega also described biochemical changes, particularly involving
calcium and glutamate. Ongoing research in this area should lead to
new treatments.
Next Dr Mega discussed the differential diagnosis of Alzheimer’ s
disease and other dementia syndromes, particularly vascular
dementias. All involve cognitive decline. In vascular dementia there
are focal neurological deficits, whereas in Alzheimer’s motor
impairment occurs only late in the disease. Behavioral abnormali
ties are the usual reason for Alzheimer’s patients to need nursing
home care. Causation and treatment of Alzheimer’s disease are the
focus of ongoing research. One issue is whether or not amyloid is
causally related to this disorder. Neurochemical changes in brain
cells are similar to those in stroke. It is hoped that research in this
area will lead to treatment and prevention of Alzheimer’s. At the
present time Tacrine is the only FDA-approved drug. FDA looks
only at cognitive changes in assessing treatment effectiveness.
Researchers at UCLA consider both cognitive and behavioral
changes and are exploring othe treatment options.
Next Dr Perez-Stable discussed cholesterol screening and the use
of cholesterol-lowering diets and drugs. Total cholesterol, LDL and
HDL should be measured. Triglycerides are not a separate risk
factor and are important only if LDL is elevated. Diet modification
is the first line of treatment. Drug therapy should be reserved for
those at highest risk (coronary or arteriosclerotic heart disease, men
age 45 to 75, women age 35 to 75) who do not respond to diet change
alone. After age 70 aggressive cholesterol lowering is probably not
necessary unless coronary heart disease is present. Other risk factors
to be considered are family history of early coronary heart disease,
tobacco use, and hypertension. Niacin lowers LDL and raises HDL.
In post-menopausal women estrogen also does both. The statins
primarily lower LDL; psyllium lowers only LDL.
With respect to cancer screening, Dr Perez-Stable noted that
effective screening requires that the number of false-positives with
a particular test be low and that early detection reduces the risk of
death from the cancer. There have been few randomized screening
trials. Screening is more valuable for groups with a high incidence
of a cancer, eg, screening smokers for oral cancer or early
mammography for women with a family history of breast cancer.
Early treatment of cervical cancer results in 90% survival. A Pap
smear every three years is adequate except for women at high risk,
and there is no need for Pap smears after age 65. Early diagnosis of
breast cancer also reduces mortality; a clinical breast exam should
be done annually from age 40 and mammography every 1 to 2 years
from age 50. For both men and women, stools should be tested for
occult blood annually from age 50, and sigmoidoscopy done every
5 to 10 years. Not recommended are chest x-ray or sputum cytology
for lung cancer, ultrasound for ovarian cancer, mammography
before age 40, and PSA for prostate cancer.
On the second morning we heard about laparoscopic surgery from
Bradley Wong MD, the medical and surgical treatment of coronary
artery disease from Irwin Schatz MD, antiviral therapy in the HIV
positive patient, and the care of patients with fatal illness by Donald
Northfelt MD, of University of California San Francisco.
According to Dr Wong, the use of laparoscopy has increased
rapidly since the first cholecystectomy in 1987 and is now being
used for many other procedures. In general, use of laparoscopic
technique can decrease pain and shorten hospital stays, reducing
costs. However, longer operative and anesthesia time, more compli
cations, and the need for expensive equipment increases costs.
Accepted procedures for the general surgeon with average skills are
cholecystectomy, appendectomy, diagnostic laparoscopy,
gastrostomy, and jejunostomy. Procedures requiring more skill are
bile-duct exploration, patching of perforating ulcer, biliary/gastric
bypass, small bowel resection, colectomy, rectal prolapse,
splenectomy, and adrenalectomy. Additional procedures now are
being developed in this rapidly evolving field.
Dr Schatz discussed the decision-making process for determining
whether to treat the patient with coronary artery disease medically
or surgically. A great deal of information exists, but there have been
no controlled studies comparing coronary artery bypass graft (CABG)
and angioplasty or medical treatment. In addition to assessment of
the individual patient (age, level of risk for future cardiovascular
events, presence or absence of symptoms, history of previous
infarction, which vessels are involved, etc), it is necessary to know
the experience, skill level, and track record of the surgeon or
cardiologist to whom the patient might be referred for invasive
treatment. In general there is little data to indicate that angioplasty
or CABG is really superior to medical treatment in low risk patients.
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For patients at moderate risk, CABG prolongs survival in those with
left main coronary artery disease or involvement of three vessels
with reduced injection fraction. For high-risk patients, CABG
prolongs survival, but in the elderly the complications are increased.
Angioplasty may be preferable to CABG in this group, but good
data are not available. Complications of CABG include myocardial
infarction in 5% to 10%, cognitive impairment (which usually
clears up) in 75%, and strokes in 5% to 8% of those 70 or older.
Survival is improved with the use of mammary arteries in grafting
instead ofsaphenous veins. Intensive medical treatment with changes
in life style and clinical risk factors can reverse coronary artery
disease and may be an alternative for some patients.
According to Dr Northfelt, the drugs currently available for HIV
disease can delay the onset of symptoms and opportunistic infec
tions; however, they do not prolong survival very much. Combina
tions of antiviral drugs may be more effective than the use of single
drugs. All of the available drugs are highly toxic and many patients
are unable to tolerate them. There is evidence that giving AZT
intravenously to infected pregnant women does reduce the risk of
transmission of the virus to the infant at the time of delivery. The
Centers for Disease Control (CDC) now recommends this practice.
Meanwhile new drugs are being developed and, it is hoped, they will
produce better results for more HIV-infected patients.
Dr Northfelt discussed caring for patients with fatal illnesses
saying the patient and the family need to be involved in planning the
care. The goal should be to reduce suffering, which patients usually
fear more than death, and improve the quality of remaining life.
Particularly important are the control of pain (“The dose that works
is the dose that works.. .No dose of morphine should be regarded as
too much”) and dyspnea (narcotics are useful here, too.) Hospice
care, preferably at home, should be made available. Hospital re
quirements for resuscitation are inhumane, and patients and fami
lies need to be told this. They should be told that, even if there is no
possibility of cure, suffering can be relieved. The families that want
to force nutrition and hydration on dying patients need to be told that
this may increase suffering. Uremic death, for instance, is painless.
Narcotics should be given as needed, and the family should be told
that the patient will just go to sleep and that any restlessness they
observe is not uncomfortable. Dr Northfelt expressed the opinion
that euthanasia should never be allowed and that assisted suicide
should not be considered unless suffering is intolerable and intrac
table and the competent patient requests it consistently.
The topic for the final morning was native Hawaiian health care.
A panel composed of Fern Clark RN, Stanford Manuia Esq,
Kahuna Laau Lapaau Helen Walrath, Kakoo Leilani Hayes, and
Drs Wayne Fukino, Ed Morgan, Steve Moser, and Terry Shintani
discussed traditional Hawaiian concepts of health and illness and
native healing practices. The ancient Hawaiians were thin, strong
and healthy people; unfortunately, today native Hawaiians have the
highest rates in the U.S. for death from heart disease, cancer, stroke,
and diabetes. In 1988 the U.S. Congress passed the Native Hawaiian
Health Care Act to address the problems in a culturally sensitive
way. There are now native Hawaiian health care programs on all
islands. Through promotion of healthier life styles, return to the
traditional Hawaiian diet, and collaboration with native healers,
changes in the grim health statistics have begun; some participants
have lost weight, lowered their blood pressure, and diabetics have
reduced or eliminated their need for insulin.
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